FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Cannabix Technologies Ramps Up Beta Testing with THC Breathalyzer and Ships Additional Devices”
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace reports that it is ramping up subject beta testing in a high-volume clinic in the Northwestern US and will ship an additional THC Breath Analyzer (“THCBA”) unit to the site. The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state. The Company also reports that it has shipped two THCBA devices to a biomedical clinic in southern Ontario for beta-testing.
Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace. Cannabix is working to develop drug-screening devices that will detect THC – the psychoactive component of marijuana that causes impairment using breath samples. Breath testing for THC would allow employers and law enforcement to identify recent marijuana use that better aligns with impairment.
For more information, please visit: Cannabix Technologies Inc.
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.
Sponsored Content Release. Click for Full Disclosure
The post “Buzz on the Street” Show: Cannabix Technologies (OTC: BLOZF) (CSE: BLO) Beta Testing Clinic first appeared on Financial Buzz .
For further details see:
“Buzz on the Street” Show: Cannabix Technologies (OTC: BLOZF) (CSE: BLO) Beta Testing Clinic